Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moses R Kamya

Showing results (1-10 of 546) with videos related to

Pageof 55
Sort By:
Future Virology|December 26, 2013
Primary prophylaxis for cryptococcal meningitis and impact on mortality in HIV: a systematic review and meta-analysisRichard Ssekitoleko, Moses R Kamya, Arthur L Reingold
Tropical Medicine & International Health : TM & IH|August 12, 2004
Asymptomatic parasitaemia as a risk factor for symptomatic malaria in a cohort of Ugandan childrenDenise Njama-Meya, Moses R Kamya, Grant Dorsey
Journal of Acquired Immune Deficiency Syndromes (1999)|September 24, 2010
Stavudine toxicity in women is the main reason for treatment change in a 3-year prospective cohort of adult patients started on first-line antiretroviral treatment in UgandaBarbara Castelnuovo, Agnes Kiragga, Moses R Kamya, et al.
Journal of the International AIDS Society|March 16, 2012
Prevalence and factors associated with cryptococcal antigenemia among severely immunosuppressed HIV-infected adults in Uganda: a cross-sectional studyJacinta Oyella, David Meya, Francis Bajunirwe, et al.
AIDS Research and Treatment|May 7, 2019
Delayed Antiretroviral Therapy (ART) Initiation among Hospitalized Adults in a Resource-Limited Settings: A Challenge to the Global Target of ART for 90% of HIV-Infected IndividualsProssie Merab Ingabire, Fred Semitala, Moses R Kamya, et al.
Journal of the International AIDS Society|July 21, 2012
Lipodystrophy among HIV-infected children and adolescents on highly active antiretroviral therapy in Uganda: a cross sectional studyThereza Piloya, Sabrina Bakeera-Kitaka, Adeodata Kekitiinwa, et al.
AIDS Reviews|November 27, 2009
Strategies to optimize HIV treatment outcomes in resource-limited settingsDamalie Nakanjako, Robert Colebunders, Alex G Coutinho, et al.
Current Opinion in HIV and AIDS|October 8, 2019
Reaching 90-90-90 in rural communities in East Africa: lessons from the Sustainable East Africa Research in Community Health TrialGabriel Chamie, Moses R Kamya, Maya L Petersen, et al.
Acta Tropica|July 16, 2011
Malaria in Uganda: challenges to control on the long road to elimination. II. The path forwardAmbrose Talisuna, Seraphine Adibaku, Grant Dorsey, et al.
BMC Cardiovascular Disorders|January 8, 2017
Rheumatic heart disease in Uganda: predictors of morbidity and mortality one year after presentationEmmy Okello, Chris T Longenecker, Andrea Beaton, et al.
Pageof 55

Showing results (1-10 of 546) with videos related to

Sort By:
Pageof 55
Future Virology|December 26, 2013
Primary prophylaxis for cryptococcal meningitis and impact on mortality in HIV: a systematic review and meta-analysisRichard Ssekitoleko, Moses R Kamya, Arthur L Reingold
Tropical Medicine & International Health : TM & IH|August 12, 2004
Asymptomatic parasitaemia as a risk factor for symptomatic malaria in a cohort of Ugandan childrenDenise Njama-Meya, Moses R Kamya, Grant Dorsey
Journal of Acquired Immune Deficiency Syndromes (1999)|September 24, 2010
Stavudine toxicity in women is the main reason for treatment change in a 3-year prospective cohort of adult patients started on first-line antiretroviral treatment in UgandaBarbara Castelnuovo, Agnes Kiragga, Moses R Kamya, et al.
Journal of the International AIDS Society|March 16, 2012
Prevalence and factors associated with cryptococcal antigenemia among severely immunosuppressed HIV-infected adults in Uganda: a cross-sectional studyJacinta Oyella, David Meya, Francis Bajunirwe, et al.
AIDS Research and Treatment|May 7, 2019
Delayed Antiretroviral Therapy (ART) Initiation among Hospitalized Adults in a Resource-Limited Settings: A Challenge to the Global Target of ART for 90% of HIV-Infected IndividualsProssie Merab Ingabire, Fred Semitala, Moses R Kamya, et al.
Journal of the International AIDS Society|July 21, 2012
Lipodystrophy among HIV-infected children and adolescents on highly active antiretroviral therapy in Uganda: a cross sectional studyThereza Piloya, Sabrina Bakeera-Kitaka, Adeodata Kekitiinwa, et al.
AIDS Reviews|November 27, 2009
Strategies to optimize HIV treatment outcomes in resource-limited settingsDamalie Nakanjako, Robert Colebunders, Alex G Coutinho, et al.
Current Opinion in HIV and AIDS|October 8, 2019
Reaching 90-90-90 in rural communities in East Africa: lessons from the Sustainable East Africa Research in Community Health TrialGabriel Chamie, Moses R Kamya, Maya L Petersen, et al.
Acta Tropica|July 16, 2011
Malaria in Uganda: challenges to control on the long road to elimination. II. The path forwardAmbrose Talisuna, Seraphine Adibaku, Grant Dorsey, et al.
BMC Cardiovascular Disorders|January 8, 2017
Rheumatic heart disease in Uganda: predictors of morbidity and mortality one year after presentationEmmy Okello, Chris T Longenecker, Andrea Beaton, et al.
Pageof 55